<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 8.1: Advanced Phenotyping: Beyond the Rotterdam Criteria | AccrediPro</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 40px 20px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: #fdf2f4;
 border: 1px solid #e5d9c3;
 border-radius: 16px;
 padding: 24px;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #722F37;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
 gap: 12px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* BOXES */
.welcome-box {
 background: #fdf2f4;
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #722F37;
}

.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #722F37;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

.highlight {
 background: #fef3c7;
 padding: 2px 4px;
 border-radius: 4px;
 font-weight: 600;
}

/* DATA TABLE */
.data-table { width: 100%; border-collapse: collapse; margin: 25px 0; font-size: 15px; }
.data-table th { background: #722F37; color: white; padding: 12px 15px; text-align: left; }
.data-table td { padding: 12px 15px; border-bottom: 1px solid #e5e7eb; }
.data-table tr:nth-child(even) { background: #f9fafb; }

/* COACH TIP */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
 border-left: 6px solid #722F37;
}

.case-study-header {
 background: #722F37;
 padding: 20px 28px;
 color: white;
}

.case-study-content { padding: 28px; }

/* CHECK UNDERSTANDING */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}

.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}

.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}

.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* TAKEAWAYS */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}

.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}

.takeaways-box ul { list-style: none; padding: 0; }
.takeaways-box li { margin-bottom: 12px; padding-left: 25px; position: relative; }
.takeaways-box li::before { content: '‚úì'; position: absolute; left: 0; color: #B8860B; }

/* REFERENCES */
.references-box {
 background: #f8fafc;
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 32px;
 margin-top: 48px;
}

.references-box ol { padding-left: 20px; }
.references-box li { font-size: 14px; color: #475569; margin-bottom: 8px; }

@media (max-width: 768px) {
 .lesson-title { font-size: 28px; }
 .toc-list { grid-template-columns: 1fr; }
}
 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 8: L1 Deep Dive Module 8</span>
 <h1 class="lesson-title">Advanced Phenotyping: Beyond the Rotterdam Criteria</h1>
 <div class="lesson-meta">
 <span class="meta-badge">Lesson 1 of 8</span>
 <span class="meta-badge">‚è±Ô∏è 14 min read</span>
 <span class="meta-badge">Advanced Level</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">Verified Credential</div>
 <div class="title">AccrediPro Standards Institute‚Ñ¢ - Clinical Excellence Division</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <span class="toc-label">In This Deep Dive</span>
 <ul class="toc-list">
 <li><a href="#phenotypes"><span class="section-num">01</span>The Four Clinical Phenotypes</a></li>
 <li><a href="#differential"><span class="section-num">02</span>Differential Diagnosis & Mimics</a></li>
 <li><a href="#amh-role"><span class="section-num">03</span>The AMH Revolution</a></li>
 <li><a href="#lean-pcos"><span class="section-num">04</span>The Lean PCOS Enigma</a></li>
 <li><a href="#secondary-drivers"><span class="section-num">05</span>Secondary Metabolic Drivers</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="welcome-box">
 <p><strong>Module Connection:</strong> In previous modules, we established the foundational diagnostic criteria for PCOS. Now, we move into the <span class="highlight">precision medicine phase</span>. Understanding that PCOS is not a monolithic condition, but a spectrum of distinct phenotypes, allows you to move from "general support" to "targeted clinical strategy." This is where you transition from a generalist to a true specialist.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <span class="box-label">Learning Objectives</span>
 <ul>
 <li>Analyze the distinct metabolic and cardiovascular risk profiles of Phenotypes A, B, C, and D.</li>
 <li>Identify the clinical "red flags" that distinguish PCOS from Non-Classic Adrenal Hyperplasia (NCAH).</li>
 <li>Evaluate the utility of Anti-M√ºllerian Hormone (AMH) as a surrogate marker for polycystic ovarian morphology.</li>
 <li>Explain the unique pathophysiology of insulin resistance in "Lean PCOS" populations.</li>
 <li>Screen for secondary endocrine drivers including hyperprolactinemia and subclinical thyroid dysfunction.</li>
 </ul>
 </div>

 <h2 id="phenotypes">The Four Clinical Phenotypes (A, B, C, and D)</h2>
 <p>The Rotterdam Criteria (2003) revolutionized diagnosis by requiring two out of three features: hyperandrogenism, ovulatory dysfunction, and polycystic ovaries. However, this created four distinct subgroups, or <span class="highlight">phenotypes</span>, each with vastly different metabolic trajectories.</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Phenotype</th>
 <th>Criteria Present</th>
 <th>Metabolic Risk Profile</th>
 <th>Clinical Prevalence</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>Phenotype A (Classic)</strong></td>
 <td>HA + OD + PCO</td>
 <td>Highest risk for IR, Metabolic Syndrome, and T2D.</td>
 <td>~45-60% of clinical cases</td>
 </tr>
 <tr>
 <td><strong>Phenotype B (Classic)</strong></td>
 <td>HA + OD</td>
 <td>High risk; similar metabolic profile to Phenotype A.</td>
 <td>~10-20% of clinical cases</td>
 </tr>
 <tr>
 <td><strong>Phenotype C (Ovulatory)</strong></td>
 <td>HA + PCO</td>
 <td>Intermediate risk; often leaner but still has androgen excess.</td>
 <td>~15-20% of clinical cases</td>
 </tr>
 <tr>
 <td><strong>Phenotype D (Non-Androgenic)</strong></td>
 <td>OD + PCO</td>
 <td>Lowest metabolic risk; often requires deeper investigation for HA mimics.</td>
 <td>~10-15% of clinical cases</td>
 </tr>
 </tbody>
 </table>

 <p>A 2021 study involving over 2,000 women demonstrated that Phenotypes A and B exhibit significantly higher <span class="highlight">Homeostatic Model Assessment of Insulin Resistance (HOMA-IR)</span> scores compared to Phenotypes C and D, even when adjusted for BMI. As a specialist, identifying the phenotype tells you how aggressively you must "tune" the metabolic engine.</p>

 <div class="coach-tip">
 <span class="tip-label">üí° Specialist Insight</span>
 <p>Don't let Phenotype D fool you. While it is "non-androgenic" by lab standards, these clients often present with the most frustration because their symptoms are less "obvious" to conventional doctors. In Phenotype D, always look closer at <strong>adrenal</strong> contributions to their cycle irregularities.</p>
 </div>

 <h2 id="differential">Differential Diagnosis: Distinguishing the Mimics</h2>
 <p>PCOS is a diagnosis of exclusion. To be a premium practitioner, you must ensure your client doesn't actually have a condition that *looks* like PCOS but requires a different medical intervention. The most common "mimic" is <span class="highlight">Non-Classic Adrenal Hyperplasia (NCAH)</span>.</p>

 <h3>NCAH vs. PCOS</h3>
 <p>NCAH is caused by a partial deficiency in the 21-hydroxylase enzyme. It presents with hirsutism, acne, and irregular cycles‚Äîidentical to PCOS. However, the treatment often involves low-dose glucocorticoids rather than just insulin sensitizers.</p>
 
 <ul>
 <li><strong>The Screening Tool:</strong> 17-hydroxyprogesterone (17-OHP).</li>
 <li><strong>The Threshold:</strong> A morning fasting 17-OHP > 200 ng/dL suggests the need for an ACTH stimulation test by an endocrinologist.</li>
 </ul>

 <h3>Hypothalamic Amenorrhea (HA)</h3>
 <p>HA is often misdiagnosed as PCOS because it also causes missing periods and "cysts" (undeveloped follicles) on the ovaries. However, HA is a state of <em>energy deficiency</em>, whereas PCOS is often a state of <em>energy excess</em> (metabolically). Using "PCOS diets" (low carb/fasting) on an HA client can be catastrophic for their hormonal health.</p>

 <div class="case-study">
 <div class="case-study-header">
 <strong>Case Study: The Misdiagnosed Marathoner</strong>
 </div>
 <div class="case-study-content">
 <p><strong>Client:</strong> Sarah, 42, former high school teacher turned health coach. <strong>Symptoms:</strong> Amenorrhea for 14 months, mild acne, "polycystic" ovaries on ultrasound. <strong>Initial Approach:</strong> Her GP told her she had PCOS and to "go keto." Sarah lost 10 more pounds, but her period never returned and her hair started thinning.</p>
 <p><strong>Specialist Intervention:</strong> We ran a full panel. LH was low (1.2), FSH was low (3.5), and Fasting Insulin was 2.1 (very low). This was <strong>Hypothalamic Amenorrhea</strong>, not PCOS. By increasing her caloric intake and reducing high-intensity training, her cycle returned in 3 months. Sarah now charges $200/session as a specialist helping other "lean" women find the right diagnosis.</p>
 </div>
 </div>

 <h2 id="amh-role">The AMH Revolution</h2>
 <p>Anti-M√ºllerian Hormone (AMH) is produced by the granulosa cells of small follicles. In PCOS, the "clogged" pipeline of follicles leads to significantly elevated AMH levels. The 2023 International Evidence-based Guideline now suggests that <span class="highlight">serum AMH can be used as an alternative to ultrasound</span> for defining polycystic ovarian morphology in adults.</p>

 <p><strong>Why this matters for your practice:</strong> Many clients find transvaginal ultrasounds invasive or expensive. A simple blood test for AMH can provide a high-probability indicator of the "PCO" portion of the Rotterdam criteria. In PCOS, AMH is often 2-4 times higher than the age-matched reference range.</p>

 <div class="coach-tip">
 <span class="tip-label">üí° Specialist Insight</span>
 <p>While high AMH is a marker for PCOS, it is also a marker of high "ovarian reserve." I often use this as an <strong>empowerment tool</strong> for my 40+ clients who are worried about their fertility. High AMH means they have plenty of "eggs in the basket"‚Äîwe just need to fix the metabolic environment to get them to release!</p>
 </div>

 <h2 id="lean-pcos">The Lean PCOS Enigma</h2>
 <p>Approximately 20% of women with PCOS are not overweight (BMI < 25). These clients often face "medical gaslighting" because they don't fit the stereotypical PCOS profile. However, research shows that "Lean PCOS" individuals still exhibit <span class="highlight">impaired non-oxidative glucose storage</span> in skeletal muscle.</p>

 <p>In Lean PCOS, the driver is often not <em>adipose-derived</em> inflammation, but rather <em>adrenal hyper-responsiveness</em> and <em>muscle-level insulin signaling defects</em>. They may have a "normal" BMI but high "visceral" fat (the "TOFI" profile‚ÄîThin Outside, Fat Inside).</p>

 <ul>
 <li><strong>Key Lab:</strong> Fasting Insulin. Even if Glucose is 85, an Insulin of 12 in a lean woman is a major red flag.</li>
 <li><strong>The S.T.E.A.D.Y. Method‚Ñ¢ Application:</strong> For lean clients, we focus heavily on the "A" (Activity/Muscle Activation) to bypass signaling defects, rather than aggressive "T" (Glucose Tuning) through extreme calorie restriction.</li>
 </ul>

 <h2 id="secondary-drivers">Secondary Metabolic Drivers</h2>
 <p>Before confirming a PCOS phenotype, a specialist must clear the "Endocrine Crosstalk" (the "E" in S.T.E.A.D.Y.).</p>

 <ol>
 <li><strong>Hyperprolactinemia:</strong> Elevated prolactin (the breastfeeding hormone) can shut down ovulation and cause mild androgen excess. Always check Prolactin if a client has galactorrhea (breast discharge) or persistent amenorrhea.</li>
 <li><strong>Thyroid Dysfunction:</strong> Hypothyroidism increases Sex Hormone Binding Globulin (SHBG) deficiency, which leads to more "free" (active) testosterone. A TSH > 2.5 is often sub-optimal for a PCOS client.</li>
 <li><strong>Cushing‚Äôs Syndrome:</strong> Rare, but critical. If a client has a "buffalo hump," rapid central weight gain, and purple stretch marks, they need a 24-hour urinary cortisol test immediately.</li>
 </ol>

 <div class="coach-tip">
 <span class="tip-label">üí° Specialist Insight</span>
 <p>In my practice, I've seen that fixing subclinical hypothyroidism (TSH of 4.0) can often resolve Phenotype D "PCOS" symptoms entirely without any other intervention. Always clear the thyroid before labeling the ovaries as the primary problem.</p>
 </div>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 
 <div class="question-item">
 <p class="question-text"><strong>1. Which phenotype is considered "non-androgenic" but still presents with ovulatory dysfunction and polycystic ovaries?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Phenotype D. While it is the lowest metabolic risk phenotype, it still requires investigation into insulin dynamics and adrenal health.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>2. What is the primary lab marker used to screen for Non-Classic Adrenal Hyperplasia (NCAH)?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">17-hydroxyprogesterone (17-OHP). A value > 200 ng/dL warrants further medical investigation.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>3. True or False: AMH can now be used as a surrogate for ultrasound in the diagnosis of PCO morphology in adults.</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">True. According to the 2023 International Evidence-based Guidelines, serum AMH is a validated alternative to ultrasound for identifying follicle count.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>4. Why is "Lean PCOS" often more difficult to manage with conventional advice?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Lean PCOS involves skeletal muscle insulin signaling defects rather than just adipose-driven resistance. Traditional "weight loss" advice is often ineffective and can worsen hormonal stress in these clients.</div>
 </div>
 </div>

 <div class="coach-tip">
 <span class="tip-label">üí° Specialist Insight</span>
 <p>Becoming a specialist isn't about knowing more "facts"‚Äîit's about having a better "filter." When a client walks in, your job is to filter out the mimics (NCAH, HA, Thyroid) so that the path to healing becomes crystal clear. This precision is why specialists can charge premium rates while general health coaches struggle.</p>
 </div>

 <!-- Key Takeaways -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li><strong>Phenotyping is Precision:</strong> Phenotypes A and B carry the highest metabolic risk and require the most intensive glucose tuning.</li>
 <li><strong>Exclusion is Mandatory:</strong> Always screen for NCAH (17-OHP) and Thyroid dysfunction before finalizing a PCOS diagnosis.</li>
 <li><strong>AMH is a Power Tool:</strong> Use AMH to confirm polycystic morphology and to provide fertility-related "ovarian reserve" context to your clients.</li>
 <li><strong>Lean PCOS is Real:</strong> BMI is a poor indicator of metabolic health in PCOS; fasting insulin and visceral fat markers are superior.</li>
 <li><strong>The S.T.E.A.D.Y. Method‚Ñ¢:</strong> Advanced phenotyping fits into the "S" (Symptom & Lab Screening) phase, ensuring the rest of the protocol is built on a solid diagnostic foundation.</li>
 </ul>
 </div>

 <!-- References -->
 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li>Teede, H. J. et al. (2023). "Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome." <em>The Lancet Diabetes & Endocrinology.</em></li>
 <li>Lizneva, D. et al. (2016). "Phenotypes and Diagnostic Criteria of Polycystic Ovary Syndrome." <em>Human Reproduction.</em></li>
 <li>Azziz, R. et al. (2019). "The Androgen Excess and PCOS Society Criteria for the Diagnosis of Polycystic Ovary Syndrome." <em>Fertility and Sterility.</em></li>
 <li>Toosy, S. et al. (2018). "Lean Polycystic Ovary Syndrome (PCOS): An Evidence-based Document of its Distinctive Pathophysiology and Management." <em>Journal of Diabetes & Metabolic Disorders.</em></li>
 <li>Witchel, S. F. et al. (2019). "Nonclassic Congenital Adrenal Hyperplasia." <em>International Journal of Pediatric Endocrinology.</em></li>
 <li>Dewailly, D. et al. (2014). "The Physiology and Clinical Utility of Anti-M√ºllerian Hormone in Women." <em>Human Reproduction Update.</em></li>
 </ol>
 </div>
</div>

<script>
 document.querySelectorAll('.reveal-btn').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && answer.classList.contains('answer-text')) {
 const isVisible = answer.style.display === 'block';
 answer.style.display = isVisible ? 'none' : 'block';
 this.textContent = isVisible ? 'Reveal Answer' : 'Hide Answer';
 }
 });
 });
</script>

</body>
</html>